相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Laboratory and Clinical Implications of Incidental and Secondary Germline Findings During Tumor Testing
Allison Cushman-Vokoun et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2022)
The effect of age on the acquisition and selection of cancer driver mutations in sun-exposed normal skin
B. Hernando et al.
ANNALS OF ONCOLOGY (2021)
Apparently Heterozygous TP53 Pathogenic Variants May Be Blood Limited in Patients Undergoing Hereditary Cancer Panel Testing
Jessica L. Mester et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2020)
Prevalence and dynamics of clonal hematopoiesis caused by leukemia-associated mutations in elderly individuals without hematologic disorders
Danica Midic et al.
LEUKEMIA (2020)
High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers
Helene Guermouche et al.
BLOOD ADVANCES (2020)
Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer A Review
Oscar Calvillo-Arguelles et al.
JAMA CARDIOLOGY (2019)
Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testing
Thomas P. Slavin et al.
CANCER GENETICS (2019)
RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues
Keren Yizhak et al.
SCIENCE (2019)
Diagnostic Utility of Next-Generation Sequencing for Disorders of Somatic Mosaicism: A Five-Year Cumulative Cohort
Samantha N. McNulty et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Next generation sequencing-based gene panel tests for the management of solid tumors
Masayuki Nagahashi et al.
CANCER SCIENCE (2019)
Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic lschemic Heart Failure
Lena Dorsheimer et al.
JAMA CARDIOLOGY (2019)
Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis
Felipe Batalini et al.
BREAST CANCER RESEARCH (2019)
Somatic TP53 variants frequently confound germ-line testing results
Jeffrey N. Weitzel et al.
GENETICS IN MEDICINE (2018)
Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome
Mariette Renaux-Petel et al.
JOURNAL OF MEDICAL GENETICS (2018)
Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels
Courtney D. DiNardo et al.
CANCER (2018)
Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays
Catherine C. Coombs et al.
CLINICAL CANCER RESEARCH (2018)
Clinical Implications of Clonal Hematopoiesis
David P. Steensma
MAYO CLINIC PROCEEDINGS (2018)
Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors
Ryan N. Ptashkin et al.
JAMA ONCOLOGY (2018)
CHIP (Clonal Hematopoiesis of Indeterminate Potential): Potent and Newly Recognized Contributor to Cardiovascular Risk
Peter Libby et al.
CIRCULATION (2018)
Clinical consequences of clonal hematopoiesis of indeterminate potential
David P. Steensma
BLOOD ADVANCES (2018)
Is incidental finding the best term?: a study of patients' preferences
Nina Tan et al.
GENETICS IN MEDICINE (2017)
Mosaicism in health and disease - clones picking up speed
Lars A. Forsberg et al.
NATURE REVIEWS GENETICS (2017)
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study
Nancy K. Gillis et al.
LANCET ONCOLOGY (2017)
Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes
L. Guidugli et al.
LEUKEMIA (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel
Bradford Coffee et al.
CANCER GENETICS (2017)
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Catherine C. Coombs et al.
CELL STEM CELL (2017)
Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life
Rocio Acuna-Hidalgo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants
Tyler F. Beck et al.
CLINICAL CHEMISTRY (2016)
Germline, hematopoietic, mosaic, and somatic variation: interplay between inherited and acquired genetic alterations in disease assessment
Eric Q. Konnick et al.
GENOME MEDICINE (2016)
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
Gaelle Bougeard et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility
Mark E. Robson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Somatic mosaicism: implications for disease and transmission genetics
Ian M. Campbell et al.
TRENDS IN GENETICS (2015)
Detecting somatic mosaicism: considerations and clinical implications
A. S. A. Cohen et al.
CLINICAL GENETICS (2015)
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Mingchao Xie et al.
NATURE MEDICINE (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)